查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1236116

肺气肿治疗全球市场规模研究与预测，按药物类型（支气管扩张剂.类固醇.其他）.分销渠道（在线供应商.药店/零售药房.医院药房）.区域分析，2022-2029 年

Global Emphysema Treatment Market Size study & Forecast, by Medication Type (Bronchodilators, Steroids, Others) By Distribution Channel (Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球肺气肿治疗市场预计约为 44.7471 亿美元，在 2022-2029 年预测期内以超过 5% 的健康增长率增长。

肺气肿是一种呼吸系统疾病。 在这种疾病中，肺部称为肺泡的小气囊会拉伸或破裂，从而损坏肺泡并导致其失去弹性。 结果，呼吸变得困难。 由于吸烟率增加和慢性阻塞性肺病患病率增加等因素，肺气肿治疗市场正在扩大。

根据 Statista 的数据，过去 100 年来，烟草製品的消费量不断增加，中国生产约 213 万吨烟草，成为世界上最大的烟草生产国。 2019年，全球有769万人死于吸烟。 推动该领域发展的另一个关键因素是慢性阻塞性肺病的日益流行。 据 Statista 称，慢性阻塞性肺病是全球第三大死因。 2019年，全球约有889万人死于缺血性心脏病。 心脏病最大的可改变风险因素是吸烟.不健康的饮食.超重和缺乏锻炼。 然而，用于肺气肿治疗的药物的副作用将阻碍整个 2022-2029 年预测期内的市场增长。

全球肺气肿治疗市场研究考虑的主要区域是亚太地区.北美.欧洲.拉丁美洲和世界其他地区。 由于肺气肿患病率高和医疗基础设施支出增加，北美在收入中占主导地位。 根据 Statista 的数据，预计 2023 年北美医疗保健领域的收入将达到 207.7 亿美元，2023 年至 2027 年的年增长率为 12.25%。 由于市场上对製造高质量肺气肿药物的投资增加等因素，预计亚太地区在预测期内将显着增长。

近期市场趋势

  • 2021 年 6 月，Tevas 宣布 PERFOROMIST（富马酸福莫特罗吸入溶液，20mcg/2ML）在美国上市，用于治疗慢性阻塞性肺疾病 (COPD) 患者的支气管收缩，包括慢性支气管炎和肺气肿。
  • 2022 年 7 月，Mylan Pharmaceuticals 获得主题专家委员会 (SEC) 的批准，该委员会隶属于中央药品标准控制组织 (CDSCO)，用于治疗慢性阻塞性肺疾病 (COPD)。我们已收到继续进行 Levefenacin Inhalation 175mcg/3ml 的 3 期临床试验。

全球市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测.公司排名.竞争格局.增长因素.趋势
  • 按地区划分：北美.欧洲.亚太地区.拉丁美洲.世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 对国家.地区和细分范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的肺气肿治疗市场
    • 2019-2029 年按药物类型划分的肺气肿治疗市场
    • 肺气肿治疗市场，按分销渠道，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球肺气肿治疗市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第 3 章肺气肿治疗的全球市场动态

  • 肺气肿治疗市场影响分析（2019-2029）
    • 市场驱动力
      • 吸烟频率增加
      • 慢性阻塞性肺病的患病率增加
    • 市场挑战
      • 用于治疗肺气肿的药物的副作用
    • 市场机会
      • 对增强型医疗保健服务的需求不断增长

第 4 章全球肺气肿治疗市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 最佳投资机会
  • 关键成功策略

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球肺气肿治疗市场：按药物类型分类

  • 市场概况
  • 全球肺气肿治疗市场：按药物类型.性能潜力分析
  • 2019-2029 年全球肺气肿治疗市场按药物类型的估计和预测
  • 肺气肿治疗市场.细分市场分析
    • 支气管扩张剂
    • 类固醇
    • 其他

第 7 章全球肺气肿治疗市场：按分销渠道

  • 市场概况
  • 全球肺气肿治疗市场：按分销渠道进行的性能潜力分析
  • 2019-2029 年肺气肿治疗全球市场估计和预测（按分销渠道）
  • 肺气肿治疗市场.细分市场分析
    • 在线提供商
    • 药店和配药店
    • 医院药房

第 8 章全球肺气肿治疗市场：区域分析

  • 肺气肿治疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按药物类型估算和预测
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲肺气肿治疗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区肺气肿治疗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲肺气肿治疗市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 辉瑞公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Teva pharmaceuticals
    • Orion corporation
    • GlaxoSmithKline plc
    • Hikma Pharmaceuticals plc
    • Verona Pharma
    • Novartis AG
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Mylan Pharmaceuticals

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Emphysema Treatment Market is valued approximately USD 4,474.71 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. Emphysema Treatment is respiratory diseases. In these conditions, lungs tiny air sac called alveoli stretch out of shape and ruptured as a result these rupture alveoli become damaged and lose its elasticity. As a result, its make difficulty in breathing. The Emphysema Treatment market is expanding because of factors such as increasing Incidence of Cigarette Smoking and increasing prevalence of chronic obstructive pulmonary disease.

According to the Statista consumption of tobacco products rose over the past century, Furthermore, China was the biggest tobacco producer worldwide with an amount of some 2.13 million metric tons of tobacco produced. In addition, annual number of deaths from smoking reached 7.69 million worldwide in 2019. Another important component driving space is the increasing prevalence of chronic obstructive pulmonary disease. As per Statista, COPD is the third leading cause of death globally. In addition, in 2019, around 8.89 million people worldwide died from ischemic heart disease. The biggest modifiable risk factors for heart disease include smoking, unhealthy diet, being overweight, and a lack of exercise. However, side effects of the drug used in Emphysema Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Emphysema Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the high incidences of emphysema and rise in spending in healthcare infrastructure. According to Statista, revenue of North America in the Health Care segment is projected to reach US$20.77bn in 2023 and projected an annual growth rate of 12.25% in between 2023 to 2027.Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising investments in manufacturing of high-quality emphysema drugs in the market space.

Major market players included in this report are:

  • Pfizer, Inc
  • Teva pharmaceuticals
  • Orion corporation
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Verona Pharma
  • Novartis AG
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Mylan Pharmaceuticals

Recent Developments in the Market:

  • In June 2021 Tevas Launch PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, used in treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema., within the United States.
  • In July 2022 Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to conduct Phase III Clinical Trial of Revefenacin inhalation solution 175 mcg/3ml to treat chronic obstructive pulmonary disease (COPD).

Global Emphysema Treatment Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Medication Type, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Medication Type:

  • Bronchodilators
  • Steroids
  • Others

By Distribution Channel:

  • Online Providers
  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Emphysema Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Emphysema Treatment Market, by Medication Type, 2019-2029 (USD Million)
    • 1.2.3. Emphysema Treatment Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Emphysema Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Emphysema Treatment Market Dynamics

  • 3.1. Emphysema Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Incidence of Cigarette Smoking
      • 3.1.1.2. Increasing prevalence of chronic obstructive pulmonary disease
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects of the drug used in emphysema treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising demand for enhanced healthcare services

Chapter 4. Global Emphysema Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Emphysema Treatment Market, by Medication Type

  • 6.1. Market Snapshot
  • 6.2. Global Emphysema Treatment Market by Medication Type, Performance - Potential Analysis
  • 6.3. Global Emphysema Treatment Market Estimates & Forecasts by Medication Type 2019-2029 (USD Million)
  • 6.4. Emphysema Treatment Market, Sub Segment Analysis
    • 6.4.1. Bronchodilators
    • 6.4.2. Steroids
    • 6.4.3. Others

Chapter 7. Global Emphysema Treatment Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Emphysema Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Emphysema Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 7.4. Emphysema Treatment Market, Sub Segment Analysis
    • 7.4.1. Online Providers
    • 7.4.2. Drug Stores and Retail Pharmacies
    • 7.4.3. Hospital Pharmacies

Chapter 8. Global Emphysema Treatment Market, Regional Analysis

  • 8.1. Emphysema Treatment Market, Regional Market Snapshot
  • 8.2. North America Emphysema Treatment Market
    • 8.2.1. U.S. Emphysema Treatment Market
      • 8.2.1.1. Medication Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Emphysema Treatment Market
  • 8.3. Europe Emphysema Treatment Market Snapshot
    • 8.3.1. U.K. Emphysema Treatment Market
    • 8.3.2. Germany Emphysema Treatment Market
    • 8.3.3. France Emphysema Treatment Market
    • 8.3.4. Spain Emphysema Treatment Market
    • 8.3.5. Italy Emphysema Treatment Market
    • 8.3.6. Rest of Europe Emphysema Treatment Market
  • 8.4. Asia-Pacific Emphysema Treatment Market Snapshot
    • 8.4.1. China Emphysema Treatment Market
    • 8.4.2. India Emphysema Treatment Market
    • 8.4.3. Japan Emphysema Treatment Market
    • 8.4.4. Australia Emphysema Treatment Market
    • 8.4.5. South Korea Emphysema Treatment Market
    • 8.4.6. Rest of Asia Pacific Emphysema Treatment Market
  • 8.5. Latin America Emphysema Treatment Market Snapshot
    • 8.5.1. Brazil Emphysema Treatment Market
    • 8.5.2. Mexico Emphysema Treatment Market
  • 8.6. Rest of The World Emphysema Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Pfizer, Inc
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Teva pharmaceuticals
    • 9.2.3. Orion corporation
    • 9.2.4. GlaxoSmithKline plc
    • 9.2.5. Hikma Pharmaceuticals plc
    • 9.2.6. Verona Pharma
    • 9.2.7. Novartis AG
    • 9.2.8. AstraZeneca
    • 9.2.9. Boehringer Ingelheim International GmbH
    • 9.2.10. Mylan Pharmaceuticals

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Emphysema Treatment Market, report scope
  • TABLE 2. Global Emphysema Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Emphysema Treatment Market estimates & forecasts by Medication Type 2019-2029 (USD Million)
  • TABLE 4. Global Emphysema Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 5. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. U.S. Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. Canada Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 19. Canada Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. UK Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 22. UK Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. Germany Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 25. Germany Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. France Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 28. France Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. Italy Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 31. Italy Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Spain Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 34. Spain Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. RoE Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 37. RoE Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. China Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 40. China Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. India Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 43. India Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. Japan Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 46. Japan Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. South Korea Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 49. South Korea Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. Australia Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 52. Australia Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. Brazil Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 58. Brazil Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Mexico Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 61. Mexico Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. RoLA Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 64. RoLA Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. Row Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 67. Row Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Emphysema Treatment Market
  • TABLE 70. List of primary sources, used in the study of global Emphysema Treatment Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Emphysema Treatment Market, research methodology
  • FIG 2. Global Emphysema Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Emphysema Treatment Market, key trends 2021
  • FIG 5. Global Emphysema Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Emphysema Treatment Market, porters 5 force model
  • FIG 7. Global Emphysema Treatment Market, pest analysis
  • FIG 8. Global Emphysema Treatment Market, value chain analysis
  • FIG 9. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Emphysema Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Emphysema Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable